The Ras-ERK pathway: Understanding site-specific signaling provides hope of new anti-tumor therapies

BioEssays

Volumn 32, Issue 5, 2010, Pages 412-421

  Calvo, Fernando ^a   Agudo Ibáñez, Lorena ^a   Crespo, Piero ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Cancer; ERK; MAP kinases; Ras; Spatial regulation of signalling

Indexed keywords

ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN; RAS PROTEIN; SCAFFOLD PROTEIN;

CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; ENDOPLASMIC RETICULUM; HUMAN; METHYLATION; NONHUMAN; PRENYLATION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 77951724799     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.200900155     Document Type: Review

References (100)

1. Roberts PJ, Der CJ. 2007. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310
2. Karnoub AE, Weinberg RA. 2008. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 9: 517-531
3. Karreth FA, Tuveson DA. 2009. Modelling oncogenic Ras/Raf signalling in the mouse. Curr Opin Genet Dev 19: 4-11.
4. Zhu K, Hamilton AD, Sebti SM. 2003. Farnesyltransferase inhibitors as anticancer agents: current status. Curr Opin Investig Drugs 4: 1428-1435 (Pubitemid 38120205)
5. Sebolt-Leopold JS, Herrera R. 2004. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4: 937-947 (Pubitemid 39626217)
6. Montagut C, Settleman J. 2009. Targeting the RAF-MEK-ERK pathway in cancer therapy. Cancer Lett 283: 125-134
7. Wong KK. 2009. Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway. Recent Pat Anticancer Drug Discov 4: 28-35.
8. Willingham MC, Pastan I, Shih TY, et al. 1980. Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry. Cell 19: 1005-1014 (Pubitemid 10155234)
9. Choy E, Chiu VK, Silletti J, et al. 1999. Endomembrane trafficking of Ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98: 69-80. (Pubitemid 29331197)
10. Philips MR. 2005. Compartmentalized signalling of Ras. Biochem Soc Trans 33: 657-661
11. Roy S, Wyse B, Hancock JF. 2002. H-Ras signaling and K-Ras signaling are differentially dependent on endocytosis. Mol Cell Biol 22: 5128-5140 (Pubitemid 34700703)
12. Gomez GA, Daniotti JL. 2005. H-Ras dynamically interacts with recycling endosomes in CHO-K1 cells: involvement of Rab5 and Rab11 in the trafficking of H-Ras to this pericentriolar endocytic compartment. J Biol Chem 280: 34997-35010
13. Rebollo A, Perez-Sala D, Martinez AC. 1999. Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: implications in prevention of apoptosis. Oncogene 18: 4930-4939 (Pubitemid 29425299)
14. Wolfman JC, Wolfman A. 2000. Endogenous c-N-Ras provides a steady-state anti-apoptotic signal. J Biol Chem 275: 19315-19323 (Pubitemid 30422905)
15. Matallanas D, Arozarena I, BercianoMT, et al. 2003. Differences in the inhibitory specificities of H-Ras, K-Ras and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization. J Biol Chem 278: 4572-4581 (Pubitemid 36800954)
16. Fehrenbacher N, Bar-Sagi D, Philips M. 2009. Ras/MAPK signaling from endomembranes. Mol Oncol 3: 297-307.
17. Prior IA, Harding A, Yan J, et al. 2001. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat Cell Biol 3: 368-375 (Pubitemid 32288444)
18. Hancock JF, Parton RG. 2005. Ras plasma membrane signalling platforms. Biochem J 389: 1-11.
19. Silvius JR. 2002. Mechanisms of Ras protein targeting in mammalian cells. J Membr Biol 190: 83-92. (Pubitemid 36930423)
20. Zhang FL, Kirschmeier P, Carr D, et al. 1997. Characterization of Haras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I. J Biol Chem 272: 10232-10239 (Pubitemid 27171703)
21. Hancock JF, Magee AI, Childs JE, et al. 1989. Ras proteins are polyisoprenylated but only some are palmytoylated. Cell 57: 1167-1177
22. Lobo S, Greentree WK, Linder ME, et al. 2002. Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae. J Biol Chem 277: 41268-41273 (Pubitemid 35215719)
23. Hancock JF, Paterson H, Marshall CJ. 1990. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell 63: 133-139 (Pubitemid 20359511)
24. Magee AI, Gutierrez L, McKay IA, et al. 1987. Dynamic fatty acylation of p21N-ras. EMBO J 6: 3353-3357
25. Goodwin JS, Drake KR, Rogers C, et al. 2005. Depalmitoylated Ras traffics to and from the Golgi complex via a nonvesicular pathway. J Cell Biol 170: 261-272 (Pubitemid 41043808)
26. Rocks O, Peyker A, Kahms M, et al. 2005. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307: 1746-1752 (Pubitemid 40388611)
27. Bivona TG, Quatela SE, Bodemann BO, et al. 2006. PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell 21: 481-493
28. Fivaz M, Meyer T. 2005. Reversible intracellular translocation of KRas but not HRas in hippocampal neurons regulated by Ca2+/calmodulin. J Cell Biol 170: 429-441 (Pubitemid 41126942)
29. Jiang X, Sorkin A. 2002. Coordinated traffic of Grb2 and Ras during epidermal growth factor receptor endocytosis visualized in living cells. Mol Biol Cell 13: 1522-1535 (Pubitemid 34522636)
30. Omerovic J, Hammond DE, Clague MJ, et al. 2008. Ras isoform abundance and signalling in human cancer cell lines. Oncogene 27: 2754-2762 (Pubitemid 351581461)
31. Jura N, Scotto-Lavino E, Sobczyk A, et al. 2006. Differential modification of Ras proteins by ubiquitination. Mol Cell 21: 679-687 (Pubitemid 43290734)
32. Prior IA, Muncke C, Parton RG, et al. 2003. Direct visualization of Ras proteins in spatially distinct cell surface microdomains. J Cell Biol 160: 165-170 (Pubitemid 36254950)
33. Paz A, Haklai R, Elad-Sfadia G, et al. 2001. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 20: 7486-7493 (Pubitemid 33086908)
34. Belanis L, Plowman SJ, Rotblat B, et al. 2008. Galectin-1 is a novel structural component and a major regulator of h-ras nanoclusters. Mol Biol Cell 19: 1404-1414 (Pubitemid 351805095)
35. Ashery U, Yizhar O, Rotblat B, et al. 2006. Spatiotemporal organization of Ras signaling: rasosomes and the galectin switch. Cell Mol Neurobiol 26: 471-495
36. Elad-Sfadia G, Haklai R, Balan E, et al. 2004. Galectin-3 augments KRas activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. J Biol Chem 279: 34922-34930 (Pubitemid 39318128)
37. Rotblat B, NivH, Andre S, et al. 2004. Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. Cancer Res 64: 3112-3118 (Pubitemid 38581411)
38. Elad-Sfadia G, Haklai R, Ballan E, et al. 2002. Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase. J Biol Chem 277: 37169-37175
39. Quilliam LA, Khosravi-Far R, Huff SY, et al. 1995. Guanine nucleotide exchange factors: activators of the Ras superfamily of proteins. Bioessays 17: 395-404.
40. Caloca MJ, Zugaza JL, Bustelo XR. 2003. Exchange factors of the RasGRP family mediate Ras activation in the Golgi. J Biol Chem 278: 33465-33473 (Pubitemid 37055801)
41. Bivona TG, Perez de Castro I, Ahearn IM, et al. 2003. Phospholipase Cg activates Ras on the Golgi apparatus by means of RasGRP1. Nature 424: 694-698 (Pubitemid 36987996)
42. Arozarena I, Matallanas D, Berciano MT, et al. 2004. Activation of H-Ras in the endoplasmic reticulum by the RasGRF family guanine nucleotide exchange factors. Mol Cell Biol 24: 1516-1530 (Pubitemid 38167075)
43. Shalom-Feuerstein R, Levy R, Makovski V, et al. 2008. Galectin-3 regulates RasGRP4-mediated activation of N-Ras and H-Ras. Biochim Biophys Acta 1783: 985-993
44. Grewal T, Enrich C. 2006. Molecular mechanisms involved in Ras inactivation: the annexin A6-p120GAP complex. Bioessays 28: 1211-1220 (Pubitemid 44925441)
45. Chiu VK, Bivona T, Hach A, et al. 2002. Ras signaling on the endoplasmic reticulum and the Golgi. Nat Cell Biol 4: 343-350 (Pubitemid 34521029)
46. Eungdamrong NJ, Iyengar R. 2007. Compartment-specific feedback loop and regulated trafficking can result in sustained activation of Ras at the Golgi. Biophys J 92: 808-815 (Pubitemid 46203211)
47. Taub N, Teis D, Ebner HL, et al. 2007. Late endosomal traffic of the epidermal growth factor receptor ensures spatial and temporal fidelity of mitogen-activated protein kinase signaling. Mol Biol Cell 18: 4698-4710 (Pubitemid 350246673)
48. Tian T, Harding A, Inder K, et al. 2007. Plasma membrane nanoswitches generate high-fidelity Ras signal transduction. Nat Cell Biol 9: 905-914 (Pubitemid 47190445)
49. Hekman M, Hamm H, Villar AV, et al. 2002. Associations of B- and C-Raf with cholesterol, phosphatidylserine, and lipid second messengers: preferential binding of Raf to artificial lipid rafts. J Biol Chem 277: 24090-32102 (Pubitemid 34951922)
50. Klysik J, Theroux SJ, Sedivy JM, et al. 2008. Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal 20: 1-9. (Pubitemid 350138364)
51. Matallanas D, Sanz-Moreno V, Arozarena I, et al. 2006. Distinct utilization of effectors and biological outcomes resulting from sitespecific Ras activation: Ras functions in lipid rafts and Golgi complex are dispensable for proliferation and transformation. Mol Cell Biol 26: 100-116
52. Plowman SJ, Ariotti N, Goodall A, et al. 2008. Electrostatic interactions positively regulate K-Ras nanocluster formation and function. Mol Cell Biol 28: 4377-4385 (Pubitemid 351904959)
53. Yan H, Chin ML, Horvath EA, et al. 2009. Impairment of ubiquitylation by mutation in Drosophila E1 promotes both cell-autonomous and noncell-autonomous Ras-ERK activation in vivo. J Cell Sci 122: 1461-1470
54. Agudo-Ibanez L, Nunez F, Calvo F, et al. 2007. Transcriptomal profiling of site-specific Ras signals. Cell Signal 19: 2264-2276 (Pubitemid 47371081)
55. Traverse S, Seedorf K, Paterson H, et al. 1994. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 4: 694-701. (Pubitemid 2120476)
56. Jaumot M, Yan J, Clyde-Smith J, et al. 2002. The linker domain of the Ha-Ras hypervariable region regulates interactions with exchange factors, Raf-1 and phosphoinositide 3-kinase. J Biol Chem 277: 272-278 (Pubitemid 34952055)
57. Hart KC, Donoghue DJ. 1997. Derivatives of activated H-ras lacking C-terminal lipid modifications retain transforming ability if targeted to the correct subcellular location. Oncogene 14: 945-953
58. Feng L, Xie X, Ding Q, et al. 2007. Spatial regulation of Raf kinase signaling by RKTG. Proc Natl Acad Sci USA 104: 14348-14353 (Pubitemid 350003264)
59. Daniels MA, Teixeiro E, Gill J, et al. 2006. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 444: 724-729 (Pubitemid 44949596)
60. Paroo Z, Ye X, Chen S, et al. 2009. Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 139: 112-122
61. Robinson MJ, Cobb MH. 1997. Mitogen-activated protein kinases pathways. Curr Opin Cell Biol 9: 180-186
62. Reszka AA, Seger R, Diltz CD, et al. 1995. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 92: 8881-8885
63. Fincham VJ, JamesM, Frame MC, et al. 2000. Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. EMBO J 19: 2911-2923
64. Glading A, Uberall F, Keyse SM, et al. 2001. Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem 276: 23341-23348 (Pubitemid 37410717)
65. Teis D, Taub N, Kurzbauer R, et al. 2006. p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis. J Cell Biol 175: 861-868 (Pubitemid 44969192)
66. Acharya U, Mallabiabarrena A, Acharya JK, et al. 1998. Signaling via mitogen-activated protein kinase kinase (MEK1) is required for Golgi fragmentation during mitosis. Cell 92: 183-192 (Pubitemid 28073042)
67. Ajenjo N, Canon E, Sanchez-Perez I, et al. 2004. Subcellular localization determines the protective effects of activated ERK2 against distinct apoptogenic stimuli in myeloid leukemia cells. J Biol Chem 279: 32813-32823 (Pubitemid 39014741)
68. Yoon S, Seger R. 2006. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24: 21-44. (Pubitemid 43108774)
69. Formstecher E, Ramos JW, Fauquet M, et al. 2001. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell 1: 239-250 (Pubitemid 33653059)
70. Ramos JW, Hughes PE, Renshaw MW, et al. 2000. Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol Biol Cell 11: 2863-2872
71. Krueger J, Chou FL, Glading A, et al. 2005. Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation. Mol Biol Cell 16: 3552-3561 (Pubitemid 41077069)
72. Whitehurst AW, Wilsbacher JL, You Y, et al. 2002. ERK2 enters the nucleus by a carrier-independent mechanism. Proc Natl Acad Sci USA 99: 7496-7501 (Pubitemid 34568719)
73. Chuderland D, Konson A, Seger R. 2008. Identification and characterization of a general nuclear translocation signal in signaling proteins. Mol Cell 31: 850-861.
74. James BP, Bunch TA, Krishnamoorthy S, et al. 2007. Nuclear localization of the ERK MAP kinase mediated by Drosophila alphaPS2betaPS integrin and importin-7. Mol Biol Cell 18: 4190-4199 (Pubitemid 47519507)
75. Casar B, Sanz-Moreno V, Yazicioglu MN, et al. 2007. Mxi2 promotes stimulus-independent ERK nuclear translocation. EMBO J 26: 635-646 (Pubitemid 46253834)
76. Gonzalez JM, Navarro-Puche A, Casar B, et al. 2008. Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope. J Cell Biol 183: 653-666
77. Dhanasekaran DN, Kashef K, Lee CM, et al. 2007. Scaffold proteins of MAP-kinase modules. Oncogene 26: 3185-3202
78. Matheny SA, Chen C, Kortum RL, et al. 2004. Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature 427: 256-260 (Pubitemid 38112042)
79. Teis D, WunderlichW, Huber LA. 2002. Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev Cell 3: 803-814 (Pubitemid 35460781)
80. Torii S, KusakabeM, Yamamoto T, et al. 2004. Sef is a spatial regulator for Ras/MAP kinase signaling. Dev Cell 7: 33-44.
81. Ishibe S, Joly D, Zhu X, et al. 2003. Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis. Mol Cell 12: 1275-1285 (Pubitemid 37487934)
82. Shenoy SK, Lefkowitz RJ. 2005. Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J Biol Chem 280: 15315-15324
83. DeFea KA, Zalevsky J, Thoma MS, et al. 2000. Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148: 1267-1281
84. Tohgo A, Choy EW, Gesty-Palmer D, et al. 2003. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem 278: 6258-6267 (Pubitemid 36800882)
85. Xiong S, Zhao Q, Rong Z, et al. 2003. hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling. J Biol Chem 278: 50273-50282 (Pubitemid 37548868)
86. Schaeffer HJ, Catling AD, Eblen ST, et al. 1998. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281: 1668-1671
87. Casar B, Arozarena I, Sanz-Moreno V, et al. 2009. Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins. Mol Cell Biol 29: 1338-1353
88. Khokhlatchev AV, Canagarajah B, Wilsbacher J, et al. 1998. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93: 605-615 (Pubitemid 28240721)
89. Burack WR, Shaw AS, 2005. Live Cell Imaging of ERK and MEK: simple binding equilibrium explains the regulated nucleocytoplasmic distribution of ERK. J Biol Chem 280: 3832-3837
90. Casar B, Pinto A, Crespo P. 2008. Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes. Mol Cell 31: 708-721
91. Glading A, Koziol JA, Krueger J, et al. 2007. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2. Cancer Res 67: 1536-1544 (Pubitemid 46383377)
92. Mebratu YA, Dickey BF, EvansC, et al. 2008. The BH3-only protein Bik/ Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death. J Cell Biol 183: 429-439
93. Chen CH, Wang WJ, Kuo JC, et al. 2005. Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. EMBO J 24: 294-304.
94. Hasan SS, Ashraf GM, Banu N. 2007. Galectins - potential targets for cancer therapy. Cancer Lett 253: 25-33. (Pubitemid 46887584)
95. Camby I, Le Mercier M, Lefranc F, et al. 2006. Galectin-1: a small protein with major functions. Glycobiology 16: 137R-57R
96. Nguyen A, Burack WR, Stock JL, et al. 2002. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol Cell Biol 22: 3035-3045 (Pubitemid 34437462)
97. Robinson MJ, Stippec SA, Goldsmith E, et al. 1998. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol 8: 1141-1150 (Pubitemid 28494712)
98. Weinstein IB, Joe A. 2008. Oncogene addiction. Cancer Res 68: 3077-80; discussion 3080.
99. Baker TL, Zheng H, Walker J, et al. 2003. Distinct rates of palmitate turnover on membrane-bound cellular and oncogenic H-ras. J Biol Chem 278: 19292-19300 (Pubitemid 36799322)
100. Mansilla F, Birkenkamp-Demtroder K, Kruhoffer M, et al. 2007. Differential expression of DHHC9 in microsatellite stable and instable human colorectal cancer subgroups. Br J Cancer 96: 1896-1903 (Pubitemid 46912029)